Want to join the conversation?
Pharmaceutical company $REGN said it presented positive preliminary results from the proof-of-concept study of evinacumab in patients with Homozygous Familial Hypercholestrolemia. The interim data showed that evinacumab added to current lipid-lowering therapy reduced low-density lipoprotein cholesterol levels by 55% versus baseline.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.